Showing 291-300 of 831 results for "".
Currents: Spotlight on Biologics
https://practicaldermatology.com/topics/psoriasis/currents-spotlight-on-biologics/23548/Currents: PsO Many Options
https://practicaldermatology.com/topics/psoriasis/currents-pso-many-options/23211/CMS 2015 - Putting Your Money Where Their Mouth Is
https://practicaldermatology.com/topics/practice-management/cms-2015---putting-your-money-where-their-mouth-is/21205/EHR User Series: Part I
https://practicaldermatology.com/topics/practice-management/ehr-user-series-part-i/22966/A Q&A series with users of EHR technology about their own experience and their broader impressions of EHR in dermatology.Harnessing Mobile Technology in Concert with EHRs
https://practicaldermatology.com/topics/practice-management/harnessing-mobile-technology-in-concert-with-ehrs/21637/Significant developments are on the way, but already EHRs offer unique abilities via mobile and tablet technologies.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0909_05-php/22769/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0209_05-php/22877/Histiocytoses: A Review of the Most Recent Classification System
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histiocytoses-a-review-of-the-most-recent-classification-system/20503/A look at the proposed new classification system, grouping the histiocytoses into five categories, with tabular summaries for differential diagnosis.Staphylococcus aureus Colonization
https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/In a recent review article, Piewngam and Otto examined the epidemiology, mechanisms, and clinical implications of Staphylococcus aureus (S. aureus) colonization, while evaluating both current and emerging strategies for decolonization.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occu